GDX News Alert Gold Miners ETF Market Vectors (GDX) 19.20 12/04/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gold Miners ETF Market Vectors (GDX) 19.20 $GDX

Gold ETFs Dip On Swiss Vote, Will India Save The Yellow Metal?
Zacks Funds - Seeking Alpha - 1 hr 47 mins ago
The year has been extremely tough for the gold bullion with all global economic data releases going against the yellow metal. The metal slipped below $1,200/oz at the end of October and is presently hovering around $1,150/oz thanks to mainly the...
PSAU: 16.66 (-0.16), RING: 7.76 (-0.18), GLDX: 10.38 (-0.52), GDXJ: 25.69 (-0.63), SGDM: 18.13 (-0.47), GLD: 115.88 (-0.45), IAU: 11.67 (-0.05), GDX: 19.20 (-0.05)

Gold ETFs Dip on Swiss Vote, Will India Save the Yellow Metal? - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Dec 03, 11:37AM CST
Easing of import rules in India should provide some support to Gold.
PSAU: 16.66 (-0.16), RING: 7.76 (-0.18), GDXJ: 25.69 (-0.63), SGDM: 18.13 (-0.47), GLD: 115.88 (-0.45), IAU: 11.67 (-0.05), GDX: 19.20 (-0.05)

Fundamentals Of Our 1% Income And Dividends Portfolio
Individual Trader - at Seeking Alpha - Wed Dec 03, 9:54AM CST

KO: 43.50 (-0.30), USO: 25.34 (-0.24), GDXJ: 25.69 (-0.63), UNG: 18.56 (-0.80), GLD: 115.88 (-0.45), MCD: 95.66 (+0.16), SLV: 15.77 (+0.04), KOL: 16.05 (+0.11), GDX: 19.20 (-0.05), CASH: 35.10 (+0.58), TBT: 50.14 (-0.82), K: 66.09 (-0.29)

Precious Metal Mining Shares Are Pointing The Way Higher For Other Commodity Producers
Steven Jon Kaplan - Seeking Alpha - Tue Dec 02, 3:11PM CST
Call me dummy and write a book for me: If the stock market falls 1%+ on a FAKE tweet, what does that mean when something serious happens? - Bette Midler Yes, you heard that right. In spite of, or really because of all the negative media hype about...
SILJ: 8.43 (-0.08), GLDX: 10.38 (-0.52), GDXJ: 25.69 (-0.63), FCG: 11.85 (-0.44), SIL: 9.28 (-0.27), COPX: 7.73 (-0.03), GXG: 13.96 (-0.24), GDX: 19.20 (-0.05)

Gold miners surge as gold closes above $1200, takeover speculation
Seeking Alpha - at Seeking Alpha - Mon Dec 01, 3:45PM CST

PSAU: 16.66 (-0.16), ABX: 11.96 (-0.37), GOLD: 66.35 (-1.06), AU: 8.81 (-0.29), GFI: 4.33 (-0.06), NEM: 19.27 (-0.36), SIL: 9.28 (-0.27), IAG: 2.35 (-0.05), NUGT: 13.29 (-0.75), RING: 7.76 (-0.18), GLDX: 10.38 (-0.52), SLVP: 8.90 (-0.28), AEM: 24.26 (-1.02), KGC: 3.13 (+0.04), PZG: 0.78 (-0.04), SGDM: 18.13 (-0.47), SLW: 21.15 (-0.51), DUST: 24.72 (+0.41), NGD: 4.41 (-0.10), RGLD: 68.36 (-1.08), AGI: 7.39 (-0.23), GDX: 19.20 (-0.05), AUY: 4.01 (-0.10), CDE: 4.22 (-0.11), GG: 20.02 (-0.66)

Why Gold Is Collapsing
Markos Kaminis - at Seeking Alpha - Mon Dec 01, 5:30AM CST

GLD: 115.88 (-0.45), ASA: 10.93 (+0.06), SLV: 15.77 (+0.04), GDX: 19.20 (-0.05)

Gold: The Verdict Is In - A Swiss Miss
Andrew Hecht - at Seeking Alpha - Mon Dec 01, 5:01AM CST
Swiss voters went to the polls and handily rejected the gold referendum on Sunday. A "yes" vote on the initiative would have required the country to dramatically increase gold reserves and repatriate the its gold holdings. Additionally, it...
GLDI: 12.40 (-0.01), OUNZ: 12.04 (-0.04), UGLD: 12.01 (-0.14), GLDE: 12.74 (-0.10), GYEN: 13.85 (-0.13), SGOL: 118.18 (-0.41), GEUR: 13.07 (-0.15), PTM: 13.67 (+0.19), SLV: 15.77 (+0.04), GDX: 19.20 (-0.05), UGL: 40.10 (-0.27), BARS: 47.29 (unch), TBAR: 25.05 (-0.05), DZZ: 7.27 (+0.05), DGL: 39.93 (-0.14), PPLT: 120.12 (+1.11), DGP: 24.41 (-0.20), DGLD: 74.08 (+0.65), UBG: 31.35 (-0.04), DGZ: 15.37 (+0.05), GLD: 115.88 (-0.45), IAU: 11.67 (-0.05), GGBP: 12.25 (-0.14), AGOL: 118.75 (unch), BAR: 29.39 (+0.18), GLL: 97.32 (+0.62)

A Red Friday For Gold Miners Creates A Trading Opportunity
Prudent Finances - at Seeking Alpha - Sun Nov 30, 11:47AM CST

GDX: 19.20 (-0.05)

'Fast Money' Recap: Eyes on OPEC Oil Meeting, Swiss Vote on Gold
at The Street - Thu Nov 27, 4:00AM CST
The trading panel discussed the price of oil, the price of gold and which companies' stocks you should buy.
FDX: 180.18 (+0.14), GPRO: 71.98 (-1.67), OIH: 37.70 (-0.29), XOP: 49.33 (-1.67), JBHT: 81.27 (+0.12), HAL: 40.74 (-0.01), BBY: 36.08 (+0.04), JBLU: 15.09 (+0.27), SDRL: 12.33 (-0.98), UPS: 110.43 (-0.47), SLW: 21.15 (-0.51), PPC: 37.59 (+1.10), GDX: 19.20 (-0.05), XLE: 81.25 (-0.71)

Why I Closed Out My Gold Short
Markos Kaminis - at Seeking Alpha - Wed Nov 26, 10:39PM CST

VXX: 26.54 (+0.02), GLD: 115.88 (-0.45), SLV: 15.77 (+0.04), NUGT: 13.29 (-0.75), GDX: 19.20 (-0.05), GG: 20.02 (-0.66)

Active Investing: Opportunity In Gold
AdvisorShares - at Seeking Alpha - Wed Nov 26, 7:41AM CST
By Tim Gramatovich, CFA, CIO and Heather Rupp, CFA, Director of Research for Peritus Asset Management, the sub-advisory firm of the AdvisorShares Peritus High Yield ETF (NYSEARCA: HYLD ) As active managers, we embrace both a top down and bottom up...
GDXJ: 25.69 (-0.63), GDX: 19.20 (-0.05)

'Fast Money' Recap: Is a Twitter Acquisition Real or Just a Tweet Dream?
at The Street - Wed Nov 26, 4:00AM CST
The trading panel looks at Hewlett-Packard, Apple and Twitter, among other stocks.
OIH: 37.70 (-0.29), GNRC: 45.68 (+0.47), M: 62.50 (-1.16), JBLU: 15.09 (+0.27), TWTR: 38.79 (-0.27), KBH: 16.30 (-0.42), GDX: 19.20 (-0.05), HPQ: 39.07 (+0.02), AAPL: 115.49 (-0.44), XRT: 92.73 (-0.64), XLE: 81.25 (-0.71), LUV: 41.39 (+0.34)

Watch for Market Vectors - Gold Miners ETF to Potentially Pullback After Gaining 4.08% Yesterday
Comtex SmarTrend(R) - Tue Nov 25, 3:36PM CST
Market Vectors - Gold Miners ETF (AMEX:GDX) traded in a range yesterday that spanned from a low of $19.62 to a high of $20.42. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $20.29 on volume of 71.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GDX: 19.20 (-0.05)

Look for Shares of Market Vectors - Gold Miners ETF to Potentially Pullback after Yesterday's 4.08% Rise
Comtex SmarTrend(R) - Tue Nov 25, 3:35PM CST
Market Vectors - Gold Miners ETF (AMEX:GDX) traded in a range yesterday that spanned from a low of $19.62 to a high of $20.42. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $20.29 on volume of 71.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GDX: 19.20 (-0.05)

Is The Gold Turning The Corner?
Ferdinando Garcia - at Seeking Alpha - Mon Nov 24, 7:23AM CST

GDXJ: 25.69 (-0.63), NEM: 19.27 (-0.36), GDX: 19.20 (-0.05), GG: 20.02 (-0.66)

Precious Metals - The Day Of Reckoning Is Coming Soon
Andrew Hecht - at Seeking Alpha - Mon Nov 24, 5:07AM CST

GLDI: 12.40 (-0.01), OUNZ: 12.04 (-0.04), UGLD: 12.01 (-0.14), GLDE: 12.74 (-0.10), GYEN: 13.85 (-0.13), SGOL: 118.18 (-0.41), GEUR: 13.07 (-0.15), PTM: 13.67 (+0.19), SLV: 15.77 (+0.04), GDX: 19.20 (-0.05), UGL: 40.10 (-0.27), BARS: 47.29 (unch), TBAR: 25.05 (-0.05), DZZ: 7.27 (+0.05), DGL: 39.93 (-0.14), PPLT: 120.12 (+1.11), DGP: 24.41 (-0.20), DGLD: 74.08 (+0.65), UBG: 31.35 (-0.04), DGZ: 15.37 (+0.05), GLD: 115.88 (-0.45), IAU: 11.67 (-0.05), GGBP: 12.25 (-0.14), AGOL: 118.75 (unch), BAR: 29.39 (+0.18), GLL: 97.32 (+0.62)

Gold Shows Strength Amid Pessimism: Medusa Mining Might Turn The Corner
Han Jun Low - at Seeking Alpha - Mon Nov 24, 3:04AM CST

GDXJ: 25.69 (-0.63), GLD: 115.88 (-0.45), GDX: 19.20 (-0.05)

This Time I Really Mean It
George Acs - at Seeking Alpha - Sat Nov 22, 9:30AM CST

KO: 43.50 (-0.30), RAI: 66.93 (+0.48), GME: 37.07 (+0.46), HAL: 40.74 (-0.01), LO: 63.90 (+0.01), GILD: 101.82 (+0.94), IBM: 164.05 (-0.47), MCD: 95.66 (+0.16), GPS: 40.56 (-0.04), TWTR: 38.79 (-0.27), GDX: 19.20 (-0.05), BHI: 57.61 (+0.08), LXK: 43.24 (+0.08)

Gold Shorts Welcome Draghi To The Rescue
Markos Kaminis - at Seeking Alpha - Fri Nov 21, 7:23AM CST

IEV: 44.68 (-0.18), GLD: 115.88 (-0.45), NUGT: 13.29 (-0.75), GDX: 19.20 (-0.05), UUP: 23.53 (-0.09), GG: 20.02 (-0.66)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles